title: Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin.
authors.affiliation: Institute of Biochemistry, University of Genoa, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tonetti
authors.forename: E
authors.initials: E
authors.lastname: Zocchi
authors.forename: L
authors.initials: L
authors.lastname: Guida
authors.forename: C
authors.initials: C
authors.lastname: Polvani
authors.forename: U
authors.initials: U
authors.lastname: Benatti
authors.forename: P
authors.initials: P
authors.lastname: Biassoni
authors.forename: F
authors.initials: F
authors.lastname: Romei
authors.forename: A
authors.initials: A
authors.lastname: Guglielmi
authors.forename: C
authors.initials: C
authors.lastname: Aschele
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
mesh_terms: D015179:Colorectal Neoplasms / Q000473:pathology; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004337:Drug Carriers; D004910:Erythrocyte Membrane / Q000187:drug effects*; D005976:Glutaral; D006801:Humans; D066298:In Vitro Techniques; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D008297:Male; D008875:Middle Aged; D013670:Sodium Pertechnetate Tc 99m
chemical_list: D004337:Drug Carriers; D004317:Doxorubicin; D013670:Sodium Pertechnetate Tc 99m; D005976:Glutaral